POINT Biopharma Global In...

NASDAQ: PNT · Real-Time Price · USD
12.50
0.02 (0.16%)
At close: Dec 26, 2023, 10:00 PM

POINT Biopharma Global Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Revenue
226.58M n/a
Cost of Revenue
n/a n/a
Gross Profit
226.58M n/a
Operating Income
125.52M -45.51M
Interest Income
4.47M 11.84K
Pretax Income
129.59M -45.6M
Net Income
98.29M -45.9M
Selling & General & Admin
19.01M 12.01M
Research & Development
82.05M 33.51M
Other Expenses
n/a n/a
Operating Expenses
101.06M 45.51M
Interest Expense
n/a 11.84K
Selling & Marketing Expenses
n/a n/a
Cost & Expenses
101.06M 45.51M
Income Tax Expense
31.29M 305.66K
Shares Outstanding (Basic)
94.6M 73.85M
Shares Outstanding (Diluted)
96.03M 73.85M
EPS (Basic)
1.04 -0.62
EPS (Diluted)
1.02 -0.62
EBITDA
127.32M -45.51M
EBIT
128.19M -45.58M
Depreciation & Amortization
1.8M 11.84K